Literature DB >> 22187772

Basaloid squamous cell carcinoma of nasopharynx: an extremely rare variety of tumour of nasopharynx.

Chhaya Roy1, Krishnangshu Bhanja Choudhury, Siddhartha Basu.   

Abstract

Nasopharyngeal carcinoma is the predominant tumour type arising in the nasopharynx with cervical lymphadenopathy present in 60-90% of all cases at the time of presentation. The most pathological varieties include squamous cell carcinoma well-differentiated keratinising, and moderately differentiated non-keratinising and an undifferentiated type. The rare variety of squamous cell carcinoma is basaloid type, according to the "WHO Classification of Tumours Pathology and Genetics: Head and Neck Tumours". In this study, we present a case of basaloid squamous cell carcinoma of nasopharynx in a 41-year female who presented with epistaxis and bilateral cervical lymphadenopathy.

Entities:  

Mesh:

Year:  2011        PMID: 22187772

Source DB:  PubMed          Journal:  J Indian Med Assoc        ISSN: 0019-5847


  3 in total

1.  PD-L1 Expression on Tumor Cells Is Associated With a Poor Outcome in a Cohort of Caucasian Nasopharyngeal Carcinoma Patients.

Authors:  Christoph Minichsdorfer; Felicitas Oberndorfer; Christoph Krall; Gabriela Kornek; Leonhard Müllauer; Christina Wagner; Thorsten Fuereder
Journal:  Front Oncol       Date:  2019-11-29       Impact factor: 6.244

2.  Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes.

Authors:  Fan Luo; Jiaxin Cao; Feiteng Lu; Kangmei Zeng; Wenjuan Ma; Yan Huang; Li Zhang; Hongyun Zhao
Journal:  Cancer Cell Int       Date:  2021-08-28       Impact factor: 5.722

3.  Dural and Multiple Brain Metastases From Basaloid Nasopharyngeal Carcinoma: Case Report and Literature Review.

Authors:  Xiaotao Geng; Furong Hao; Guiyan Han; Yaping Zhang; Peiyan Qin
Journal:  Front Oncol       Date:  2021-07-14       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.